PMN: ProMIS Neurosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 16.98
Enterprise Value ($M) 8.62
Book Value ($M) 9.47
Book Value / Share 0.29
Price / Book 1.79
NCAV ($M) 9.47
NCAV / Share 0.29
Price / NCAV 1.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.10
Return on Assets (ROA) -0.26
Return on Equity (ROE) -12.11

Liquidity (mrq)
Quick Ratio 3.36
Current Ratio 3.36

Balance Sheet (mrq) ($M)
Current Assets 13.65
Assets 13.65
Liabilities 4.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -16.83
Net Income 2.78

Cash Flow Statement (mra) ($M)
Cash From Operations -27.18
Cash from Investing -0.00
Cash from Financing 27.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 7.68 -5.99
02-14 13G/A Great Point Partners Llc 9.99 10.89
11-06 13G/A Sclar Jeremy M. 19.10 77.92
11-05 13G/A Gordon Michael S 14.00 77.07
10-16 13G Shaf QIC LLC 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 4,759 90,509 5.26
2025-05-12 39,314 211,949 18.55
2025-05-09 5,441 41,760 13.03
2025-05-08 20,811 150,594 13.82

(click for more detail)

Similar Companies
PHIO – Phio Pharmaceuticals Corp. PLUR – Pluri Inc.
PMCB – PharmaCyte Biotech, Inc. PRFX – PainReform Ltd.
PROK – ProKidney Corp.


Financial data and stock pages provided by
Fintel.io